Document is current
Any future updates will be listed below
-
Authors
Fear, Vanessa S. https://orcid.org/0000-0001-8363-6685
Forbes, Catherine A.
Shaw, Nicole C.
Farley, Kathryn O.
Mantegna, Jessica L.
Htun, Jasmin P.
Syn, Genevieve
Viola, Helena
Cserne Szappanos, Henrietta
Hool, Livia
Ward, Michelle
Baynam, Gareth
Lassmann, Timo
-
Funding
Funding for this research was provided by:
McCusker Charitable Foundation (Lassmann)
Feilman Foundation (Lassmann)
Stan Perron Charitable Foundation (Lassmann)
Department of Health, Government of Western Australia (Fear)
- License Information
-
More Information
Article History
Received: 23 February 2023
Accepted: 29 November 2023
First Online: 5 December 2023
Declarations
:
: This human study entitled “Bringing the benefits of precision medicine to children in Western Australia” was approved by the Child and Adolescent Health Services, Human Research Ethics Committee. Approval number RGS0000000166. Date of approval 7<sup>th</sup> August, 2017. Principal Investigator, Timo Lassmann. The patient recruitment to this study was initiated with contact to the patient’s parent by a genetic counsellor based at Genome Services Western Australia. Next, a member of the research team contacted the parent to provide study information, and the patient’s parent completed the patient information consent form for participation in the study. The study adhered with the Declaration of Helsinki and the NHMRC National Statement on Ethical Conduct Human Ethics Research. Approved by the Child and Adolescent Health Services, Human Research Ethics Committee, RGS0000000166.
: Not applicable.
: The authors declare they have no competing interests.
